Pralatrexate

In the US, Pralatrexate (pralatrexate systemic) is a member of the drug class antimetabolites and is used to treat Lymphoma and Non-Hodgkin's Lymphoma.

US matches:

• Pralatrexate


• Pralatrexate Intravenous

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L01BA05

CAS registry number (Chemical Abstracts Service)

0146464-95-1

Chemical Formula

C23-H23-N7-O5

Molecular Weight

477

Therapeutic Category

Antineoplastic agent

Chemical Names

N-(4-{1-[(2,4-diaminopteridin-6-yl)methyl]but-3-yn-1-yl}benzoyl)-L-glutamic acid (IUPAC)

N-{4-[1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl]benzoyl}-L-glutamic acid (WHO)

(2S)-2-[[4-[(1RS)-1-[(2,4-Diaminopteridin-6-yl)methyl]but-3-ynyl]benzoyl]amino]pentanedioic acid (USAN)

10-Propargyl-10-deazaaminopterin

L-Glutamic acid, N-[4-[1-[(2,4-diamino-6-pteridinyl)methyl]-3-butynyl]benzoyl]- (USAN)

Foreign Names

• Pralatrexatum (Latin)
• Pralatrexat (German)
• Pralatrexate (French)
• Pralatrexato (Spanish)

Generic Names

• Pralatrexate (OS: USAN)
• PDX (IS)
• UNIIA8Q8I19Q20 (IS)

Brand Name

• Folotyn
  Allos, United States

International Drug Name Search

Glossary

IUPAC	International Union of Pure and Applied Chemistry
IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.